2.501 - 2.525 of 34.575
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Gilead Sciences Call 200,00 18 Sep 2026
- Goldman Sachs
- 18.09.26
- 5,42x
- Analysis
- Meta Platforms Call 1.020,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 16,75x
- Analysis
- Moderna Call 24,00 17 Oct 2025
- Goldman Sachs
- 17.10.25
- 4,61x
- Analysis
- Novo Nordisk Call 475,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,42x
- Analysis
- Novo Nordisk Call 355,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,91x
- Analysis
- Novo Nordisk Call 255,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,34x
- Analysis
- Henkel Vz. Call 72,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 17,70x
- Analysis
- Meta Platforms Call 810,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 24,05x
- Analysis
- Novo Nordisk Call 525,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,78x
- Analysis
- Novo Nordisk Call 415,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,18x
- Analysis
- Novo Nordisk Call 295,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,64x
- Analysis
- Novo Nordisk Call 305,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,70x
- Analysis
- Novo Nordisk Call 275,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,49x
- Analysis
- Novo Nordisk Call 385,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,93x
- Analysis
- Novo Nordisk Call 465,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,42x
- Analysis
- Novo Nordisk Call 395,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,39x
- Analysis
- Novo Nordisk Call 355,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 3,09x
- Analysis
- Novo Nordisk Call 455,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,40x
- Analysis
- Novo Nordisk Call 325,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,34x
- Analysis
- Novo Nordisk Call 325,00 18 Dec 2026
- Goldman Sachs
- 18.12.26
- 2,86x
- Analysis
- Novo Nordisk Call 475,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,98x
- Analysis
- Novo Nordisk Call 365,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,77x
- Analysis
- Novo Nordisk Call 375,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,85x
- Analysis
- Novo Nordisk Call 355,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,67x
- Analysis
- Novo Nordisk Call 435,00 19 Dec 2025
- Goldman Sachs
- 19.12.25
- 6,06x
- Analysis